Dengvaxia controversy: impact on vaccine hesitancy
- PMID: 30410732
- PMCID: PMC6214489
- DOI: 10.7189/jogh.08.020312
Dengvaxia controversy: impact on vaccine hesitancy
Conflict of interest statement
Competing interests: The authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare no conflict of interest.
Figures
References
-
- World Health Organization. Dengue and severe dengue. 2018. Available: http://www.who.int/en/news-room/fact-sheets/detail/dengue-and-severe-dengue. Accessed: 16 April 2018.
-
- World Health Organization. Global strategy for dengue prevention and control. 2012. Available: http://apps.who.int/iris/bitstream/handle/10665/75303/9789241504034_eng..... Accessed: 16 April 2018.
-
- World Health Organization. Updated Questions and Answers related to the dengue vaccine Dengvaxia® and its use. 2017. Available: http://www.who.int/immunization/diseases/dengue/q_and_a_dengue_vaccine_d.... Accessed: 16 April 2018.
-
- The New York Times. Drug company under fire after revealing dengue vaccine may harm some. 2017. Available:https://www.nytimes.com/2017/12/17/health/sanofi-dengue-vaccine-philippi.... Accessed: 16 April 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical